STOCK TITAN

Eve Holding (EVEX) Financials

EVEX NYSE
Trailing 12 months to September 30, 2026
Net Income -$225.0M n/m YoY
EPS (Diluted) -$0.64 n/m YoY
Free Cash Flow -$200.0M n/m YoY
Operating Cash Flow -$192.9M n/m YoY
Market Cap $404.3M as of Nov 20, 2026
Price / Sales n/m no revenue reported
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EVEX SEC filings page.

This page shows Eve Holding, Inc. (EVEX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EVEX FY2025

The business remains a development-focused operation, with escalating R&D and cash use increasingly funded by external financing.

FY2025's net loss reached $224.3M while operating cash flow was -$160.4M, so the accounting loss translated into a somewhat smaller cash outflow. Financing cash flow of $263.1M indicates development activity was funded primarily outside operations rather than by internally generated cash.

R&D reached $194.7M in FY2025, up 49.9% from FY2024; that spending is the central operating commitment behind the company's losses. Capital expenditures also reached $12.6M, while free cash flow was -$173.0M, showing cash needs extend beyond reported R&D.

Liabilities reached $311.1M against equity of $123.8M in FY2025, making the balance sheet materially more leveraged than in earlier periods. Debt-to-equity reached 1.4x while the current ratio remained 3.3x, indicating increased leverage without eliminating near-term asset coverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Eve Holding, Inc., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

Eve Holding, Inc. passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality No Cash Backing
N/A

Eve Holding, Inc. reported a net loss of $224.3M while operations used $160.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Eve Holding, Inc. reported an operating loss of $225.4M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA
-$53.8M
YoYn/m
QoQn/m

Eve Holding, Inc.'s EBITDA was -$53.8M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$58.1M
YoYn/m
QoQn/m

Eve Holding, Inc. reported a net loss of $58.1M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.16
YoYn/m
QoQn/m
5Y CAGRn/m

Eve Holding, Inc. earned -$0.16 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
-$53.0M
YoYn/m
QoQn/m

Eve Holding, Inc. recorded an outflow of $53.0M in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$119.4M
YoY+81.4%
QoQ+128.7%
5Y CAGR+52.1%

Eve Holding, Inc. held $119.4M in cash against $313.6M in long-term debt as of Q3 2026.

Shares Outstanding
348M
YoY+0.1%
QoQ0.0%
5Y CAGR+9.6%

Eve Holding, Inc. had 348M shares outstanding in Q3 2026. This represents an increase of 0.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

None of these metrics is reported for Q3 2026.

Capital Allocation

R&D Spending
$48.3M
YoY+7.6%
QoQ+66.9%

Eve Holding, Inc. invested $48.3M in research and development in Q3 2026. This represents an increase of 7.6% from the same quarter a year earlier. Against the prior quarter it is up 66.9%.

Capital Expenditures
$1.4M
YoY-79.6%
QoQ+22.1%

Eve Holding, Inc. invested $1.4M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 79.6% from the same quarter a year earlier. Against the prior quarter it is up 22.1%.

Share Buybacks

Not reported for Q3 2026.

EVEX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVEX quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
R&D Expenses$48.3M+7.6%$28.9M-36.7%$59.1M+32.1%$59.4M+76.6%$44.9M+38.4%$45.7M+25.8%$44.7M+62.9%$33.7M+0.2%
SG&A Expenses$6.0M-15.1%$8.3M+1.2%$7.2M-8.2%$7.6M+21.3%$7.0M-16.5%$8.2M+51.9%$7.9M+21.8%$6.2M+18.2%
Operating Income-$54.3Mn/m-$37.2Mn/m-$66.3Mn/m-$67.0Mn/m-$51.9Mn/m-$53.9Mn/m-$52.6Mn/m-$39.9Mn/m
EBITDA-$53.8Mn/m-$36.7Mn/m-$65.9Mn/m-$66.6Mn/m-$51.5Mn/m-$53.8Mn/m-$52.5Mn/m-$39.8Mn/m
Interest Expense$5.5M+107.6%$5.2M+118.9%$4.6M+106.8%$2.8M+58.1%$2.7M+219.9%$2.4M+289.6%$2.2M+442.2%$1.8M+714.9%
Income Tax$3.0M+143.4%-$2.9M-759.8%$95Kn/m-$95Kn/m$1.2M+186.9%$435K+10.1%-$558K-189.6%-$938Kn/m
Net Income-$58.1Mn/m-$34.2Mn/m-$68.8Mn/m-$63.9Mn/m-$46.9Mn/m-$64.7Mn/m-$48.8Mn/m-$40.7Mn/m
EPS (Basic)-$0.16n/m-$0.10n/m-$0.20n/m-$0.18n/m-$0.14n/m-$0.21n/m-$0.16n/m-$0.14n/m
EPS (Diluted)-$0.16n/m-$0.10n/m-$0.20n/m-$0.18n/m-$0.14n/m-$0.21n/m-$0.16n/m-$0.14n/m
Diluted Shares (Avg)352M+7.9%352M+15.8%352M+15.9%N/A326M+9.5%304M+9.9%304M+9.9%N/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit.

EVEX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVEX quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'25FilingQ4'2410-K
Total Assets$409.5M-6.9%$457.7M+75.4%$484.3M+59.2%$434.9M+36.6%$439.7M+51.9%$261.0M+21.6%$304.2M+33.2%$318.2M+29.7%
Current Assets$373.7M-12.0%$421.2M+68.4%$456.7M+53.4%$410.9M+31.4%$424.7M+48.8%$250.1M+18.9%$297.6M+32.7%$312.8M+29.1%
Cash & Equivalents$119.4M+81.4%$52.2M+25.7%$120.9M+103.2%$103.2M+83.1%$65.8M+168.0%$41.5M+49.6%$59.5M+152.3%$56.4M+20.2%
Short-Term Investments$228.4M-33.7%$342.5M+70.2%$311.6M+36.6%$280.8M+13.7%$344.2M+34.9%$201.2M+115.8%$228.1M+98.8%$247.0M+122.1%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$443.9M+73.7%$434.9M+75.7%$428.2M+87.8%$311.1M+60.1%$255.6M+103.1%$247.6M+126.2%$228.0M+160.8%$194.3M+142.0%
Current Liabilities$119.1M+46.2%$121.2M+34.4%$120.3M+45.5%$124.8M+110.3%$81.5M+48.8%$90.2M+66.0%$82.7M+82.9%$59.3M+14.1%
Non-Current Liabilities$324.8M+86.5%$313.7M+99.3%$307.9M+111.8%$186.3M+38.1%$174.1M+145.0%$157.4M+185.5%$145.4M+244.2%$135.0M+377.0%
Long-Term Debt$313.6M+87.5%$303.1M+96.8%$295.8M+108.1%$176.4M+33.6%$167.3M+144.9%$154.0M+192.8%$142.2M+255.1%$132.0M+412.4%
Total Equity-$34.5M-118.7%$22.8M+69.9%$56.1M-26.4%$123.8M-0.1%$184.1M+12.5%$13.4M-87.2%$76.1M-46.0%$123.9M-24.9%
Retained Earnings-$868.2Mn/m-$810.1Mn/m-$775.9Mn/m-$707.1Mn/m-$643.2Mn/m-$596.3Mn/m-$531.6Mn/m-$482.8Mn/m

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.

EVEX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVEX quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$51.6Mn/m-$47.2Mn/m-$68.1Mn/m-$25.9Mn/m-$54.0Mn/m-$55.6Mn/m-$24.9Mn/m-$38.7Mn/m
Depreciation & Amortization$497K+40.8%$517K+383.2%$394K+380.5%$388K+410.5%$353K+426.9%$107K+84.5%$82K+60.8%$76K+85.4%
Stock-Based CompensationN/AN/A$1.1M+10.6%N/AN/AN/A$1.0M-11.0%N/A
Capital Expenditures$1.4M-79.6%$1.1M-10.7%$526K+13.4%$4.1M+237.5%$6.7M+108.0%$1.3M+90.9%$464K+337.7%$1.2Mn/m
Free Cash Flow-$53.0Mn/m-$48.3Mn/m-$68.6Mn/m-$30.0Mn/m-$60.7Mn/m-$56.9Mn/m-$25.3Mn/m-$39.9Mn/m
Investing Cash Flow$105.5Mn/m-$30.1M-212.7%-$31.5M-270.1%$57.7M+897.7%-$149.7Mn/m$26.7M+25.3%$18.5Mn/m$5.8M-87.7%
Financing Cash Flow$13.3M-94.2%$9.1M-18.8%$117.1M+1161.9%$12.8M-80.4%$229.9M+111.3%$11.2M-21.4%$9.3M-37.1%$65.2M+359.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

EVEX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVEX quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Return on EquityN/A-149.9%+331.6pp-122.8%-58.7pp-51.6%-18.8pp-25.5%-3.6pp-481.5%-446.9pp-64.1%-46.1pp-32.8%-9.1pp
Return on Assets-14.2%-3.5pp-7.5%+17.3pp-14.2%+1.8pp-14.7%-1.9pp-10.7%+1.7pp-24.8%-7.8pp-16.0%-5.0pp-12.8%+3.2pp
Current Ratio3.14-2.1x3.48+0.7x3.80+0.2x3.29-2.0x5.210.0x2.77-1.1x3.60-1.4x5.27+0.6x
Debt-to-EquityN/A13.28+1.8x5.28+3.4x1.43+0.4x0.91+0.5x11.46+11.0x1.87+1.6x1.07+0.9x
Liabilities-to-EquityN/A19.05+0.6x7.64+4.6x2.51+0.9x1.39+0.6x18.43+17.4x3.00+2.4x1.57+1.1x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Eve Holding, Inc. EVEX FY2025 N/A -$224.3M N/A $404.3M —
Kopin Corp KOPN FY2025 $39.3M $2.6M 6.6% $479.0M 32/100
Red Cat Holdings, Inc. RCAT FY2025 $40.7M -$72.1M N/A $274.6M 53/100
Park Aerospace Corp. PKE FY2026 $73.3M $11.3M 15.4% $494.2M 80/100
Satellogic Inc. SATL FY2025 $17.7M -$4.8M -27.0% $379.8M 61/100
TAT Technologies Ltd TATT FY2025 $178.0M $16.8M 9.4% $454.0M 65/100

Frequently Asked Questions

No, Eve Holding, Inc. (EVEX) reported a net loss of $225.0M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $224.3M.

Eve Holding, Inc. (EVEX) reported diluted earnings per share of -$0.70 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Eve Holding, Inc. (EVEX) had EBITDA of -$224.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Eve Holding, Inc. (EVEX) had $103.2M in cash and equivalents against $176.4M in long-term debt.

Eve Holding, Inc. (EVEX) has a return on equity of -181.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Eve Holding, Inc. (EVEX) recorded an outflow of $173.0M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Eve Holding, Inc. (EVEX) recorded an outflow of $160.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Eve Holding, Inc. (EVEX) had $434.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Eve Holding, Inc. (EVEX) invested $12.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Eve Holding, Inc. (EVEX) invested $194.7M in research and development during fiscal year 2025.

Eve Holding, Inc. (EVEX) had 348M shares outstanding as of fiscal year 2025.

Eve Holding, Inc. (EVEX) had a current ratio of 3.29 as of fiscal year 2025, which is generally considered healthy.

Eve Holding, Inc. (EVEX) had a debt-to-equity ratio of 1.43 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Eve Holding, Inc. (EVEX) had a liabilities-to-equity ratio of 2.51 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Eve Holding, Inc. (EVEX) had a return on assets of -51.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Eve Holding, Inc. (EVEX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $404.3M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Eve Holding, Inc. (EVEX) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $404.3M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Eve Holding, Inc. (EVEX) held $384.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $160.4M over that year. Dividing the one by the other, the reported balance equals about 29 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Eve Holding, Inc. (EVEX) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Eve Holding, Inc. (EVEX) reported a net loss of $224.3M while operations used $160.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Eve Holding, Inc. (EVEX) reported an operating loss of $225.4M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top